热门资讯> 正文
MannKind首席财务官Steven Binder退休
2024-03-27 04:13
- MannKind (NASDAQ:MNKD) announced that Steven Binder will retire from his position as Chief Financial Officer, effective April 22, 2024.
- Christopher Prentiss has been appointed as CFO, effective April 22, 2024.
- Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
- Since September 2022, Prentiss has served as CFO of ADARx Pharmaceuticals, a privately held clinical-stage biotechnology company. He also held a series of finance positions at the commercial-stage biotech company Adamas Pharmaceuticals.
More on MannKind
- MannKind's Tyvaso DPI Royalty Deal Signals Undervaluation
- MannKind Q4 2023 Earnings Preview
- MannKind, Sagard Healthcare enter $200M royalty purchase deal
- Seeking Alpha’s Quant Rating on MannKind
推荐文章
一图看懂 | 利润骤降！美团Q2净利同比降低89%至14.9亿元，大幅低于预期
华盛早报 | 苹果最新官宣！秋季发布会定档9月9日；特朗普欲控制美联储“多数席位”以推动降息
美联储首次回应“理事遭开除”事件，特朗普宣称“降息派”很快占上风！
8月27日外盘头条：苹果将于9月9日举行发布会 特朗普与美联储库克斗争加剧 美国政府将入股目光投向国防产业
苹果将于9月9日举行发布会 推出iPhone 17系列和升级版手表
分析：美联储的公信力是重要资产，其受损或代价高昂
美股机会日报 | 大摩改变立场！预计美联储今年降息2次；回声星通信一度飙升逾80%
财报前瞻 | “地球上最重要财报”来袭！英伟达Q2能否交出完美答卷？华尔街大行绩前集体看涨
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
